IRIS

Sfoglia per Rivista  ONCOGENE

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 51
Titolo Data di pubblicazione Autore(i) File
A mutated p53 gene alters thyroid cell differentiation 1-gen-1995 Battista, S; Martelli, Ml; Fedele, M; Chiappetta, G; Trapasso, F; DE VITA, G; Battaglia, C; Santoro, M; Fagin, Ja; Et, Al; Viglietto, G
A PH-DEPENDENT DIFFERENTIAL CYTO-TOXICITY OF OUABAIN FOR HUMAN-CELLS TRANSFORMED BY CERTAIN ONCOGENES 1-gen-1988 Talbot, N; Tagliaferri, P; Yanagihara, K; Rhim, Js; Bassin, Rh; Benade, Le
Activating mutations of the TSH Receptor in differentiated thyroid carcinomas 1-gen-1995 Russo, D.; Schlumberger, M; Caillou, B; Monier, R; Arturi, F
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells 1-gen-2003 Visconti, R; Schepis, F; Pierantoni, Gm; Zhang, L; Carlomagno, F; Battaglia, C; Martelli, Ml; Trapasso, F; Santoro, M; Fusco, A; Iuliano, R
Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland 1-gen-2003 Motti, Ml; Boccia, A; Belletti, B; Bruni, P; Troncone, G; Cito, L; Monaco, M; Chiappetta, G; Baldassarre, G; Palombini, L; Fusco, A; Viglietto, G
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth 1-gen-2016 Morrison, Mm; Williams, Mm; Vaught, Db; Hicks, D; Lim, J; Mckernan, C; Aurisicchio, L; Ciliberto, G; Simion, C; Sweeney, C; Cook, Rs
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1 1-gen-1997 Baldassarre, G; Romano, A; Armenante, F; Rambaldi, M; Paoletti, I; Sandomenico, C; Pepe, S; Staibano, S; Salvatore, G; DE ROSA, G; Persico, Mg; Viglietto, G
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression 1-gen-1997 Visconti, R; Cerutti, J; Battista, S; Fedele, M; Trapasso, F; Zeki, K; Miano, Mp; DE NIGRIS, F; Casalino, L; Curcio, F; Santoro, M; Fusco, A
Expression profiling in epithelial plasticity in tumor progression 1-gen-2003 Jechlinger, M; Grunert, S; Tamir, Ih; Janda, E; Lüdemann, S; Waerner, T; Seither, P; Weith, A; Beug, H; Kraut, N
Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential 1-gen-2006 Semba, S; Trapasso, F; Fabbri, M; Mccorkell, Ka; Volinia, S; Druck, T; Iliopoulos, D; Pekarsky, Y; Ishii, H; Garrison, Pn; Barnes, Ld; Croce, Cm; Huebner, K
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 1-gen-2012 Berardi, S; Caivano, A; Ria, R; Nico, B; Savino, R; Terracciano, R; De Tullio, G; Ferrucci, A; De Luisi, A; Moschetta, M; Mangialardi, G; Catacchio, I; Basile, A; Guarini, A; Zito, A; Ditonno, P; Musto, P; Dammacco, F; Ribatti, D; Vacca, A
Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells 1-gen-2013 Masciarelli, S.; Fontemaggi, G.; Di Agostino, S.; Donzelli, S.; Carcarino, E.; Strano, S.; Blandino, G.
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1) 1-gen-2002 Baldassarre, G; Bruni, P; Boccia, A; Salvatore, G; Melillo, Rm; Motti, Ml; Napolitano, M; Belletti, B; Fusco, A; Santoro, M; Viglietto, G
High level expression of the HMGI (Y) gene during embryonic development 1-gen-1996 Chiappetta, G; Avantaggiato, V; Visconti, R; Fedele, M; Battista, S; Trapasso, F; Merciai, Bm; Fidanza, V; Giancotti, V; Santoro, M; Simeone, A; Fusco, A
High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth 1-gen-2001 Pierantoni, Gm; Fedele, M; Pentimalli, F; Benvenuto, G; Pero, R; Viglietto, G; Santoro, M; Chiariotti, L; Fusco, A.
HMGA1 and HMGA2 protein expression in mouse spermatogenesis 1-gen-2002 Chieffi, P.; Battista, S.; Barchi, M.; Di Agostino, S.; Maria Pierantoni, G.; Fedele, M.; Chiariotti, L.; Tramontano, D.; Fusco, A.
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 1-gen-2018 di Martino, S1; Amoreo, Ca2; Nuvoli, B; Galati, R; Strano, S; Facciolo, F; Alessandrini, G; Pass, Hi; Ciliberto, G; Blandino, G; De Maria, R; Cioce, M
In vivo hepatocyte proliferation is inducible through a TNF and IL-6-Independent pathway 1-gen-1998 LEDDA-COLUMBANO, G. M.; Curto, M.; Piga, R.; Zedda, A. I.; Menegazzi, M.; Sartori, C.; Shinozuka, H.; Bluethmann, H.; Poli, V.; Ciliberto, G; Columbano, A.
Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo 1-gen-1998 Battista, S; DE NIGRIS, F; Fedele, M; Chiappetta, G; Scala, S; Vallone, D; Pierantoni, Gm; Mega, T; Santoro, M; Viglietto, G; Verde, P; Fusco, A.
Inducible formation of liver tumors in transgenic mice 1-gen-1993 Ruther, U.; Woodroofe, C.; Fattori, E.; Ciliberto, G
Mostrati risultati da 1 a 20 di 51
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile